This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
This page is a summary of: A UK-Based Cost-Utility Analysis of Indacaterol, A Once-Daily Maintenance Bronchodilator for Patients with COPD, Using Real World Evidence on Resource Use, Applied Health Economics and Health Policy, March 2013, Springer Science + Business Media,
DOI: 10.1007/s40258-013-0021-5.
You can read the full text:
The following have contributed to this page
American Journal of Economics and Sociology
Climate change is happening, and we have been forewarned of the consequences. Since it is caused largely by human action, a lot can be done to avert the detrimental consequences. But getting politi...
International Review of Economics & Finance
This paper analyzes the effect of financial leverage on corporate operating performance and how this effect varies across countries. Results for 10,375 firms in 39 countries indicate that the perfo...
Scottish Journal of Political Economy
How does fiscal decentralization influence fiscal discipline and the probability of a fiscal crisis?
